Zobrazeno 1 - 10
of 425
pro vyhledávání: '"C. Panetta"'
Autor:
F. Magri, M. G. Donà, C. Panetta, M. Pontone, F. Pimpinelli, N. Cameli, A. Cristaudo, M. Zaccarelli, A. Latini
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background The clinical manifestations of recent syphilis can be variable, with typical and atypical patterns. Several conditions may cause atypical clinical aspects, including human immunodeficiency virus (HIV) co-infection. Besides the cli
Externí odkaz:
https://doaj.org/article/2ccd54125a214936a8a53cb542be5f43
Autor:
Marla C. Dubinsky, Shervin Rabizadeh, John C. Panetta, Elizabeth A. Spencer, Annelie Everts-van der Wind, Thierry Dervieux
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2408 (2023)
Infliximab (IFX) concentrations are a predictive factor (PF) of pharmacokinetic (PK) origin in the treatment of Crohn’s disease (CD). We evaluated Clearance, another PF of PK origin, either alone or in combination with concentrations. They were eva
Externí odkaz:
https://doaj.org/article/dea09ccc678a456c878679f1158b2931
Autor:
Aditya H. Gaur, John C. Panetta, Amber M. Smith, Ronald H. Dallas, Burgess B. Freeman, III, Tracy B. Stewart, Li Tang, Elizabeth John, Kristen C. Branum, Nehali D. Patel, Shelley Ost, Ryan N. Heine, Julie L. Richardson, Jared T. Hammill, Lidiya Bebrevska, Fabian Gusovsky, Noritsugu Maki, Toshiharu Yanagi, Patricia M. Flynn, James S. McCarthy, Stephan Chalon, R. Kiplin Guy
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104065- (2022)
Summary: Background: SJ733, a newly developed inhibitor of P. falciparum ATP4, has a favorable safety profile and rapid antiparasitic effect but insufficient duration to deliver a single-dose cure of malaria. We investigated the safety, tolerability,
Externí odkaz:
https://doaj.org/article/d8cb0aafdaa14141ac20c3e2254e7c3d
Autor:
Seth E. Karol, Deqing Pei, Colton A. Smith, Yiwei Liu, Wenjian Yang, Nancy M. Kornegay, John C. Panetta, Kristine R. Crews, Cheng Cheng, Emily R. Finch, Hiroto Inaba, Monika L. Metzger, Jeffrey E. Rubnitz, Raul C. Ribeiro, Tanja A. Gruber, Jun J. Yang, William E. Evans, Sima Jeha, Ching-Hon Pui, Mary V. Relling
Publikováno v:
Haematologica, Vol 107, Iss 2 (2021)
Chemotherapy dosages are often compromised, but most reports lack data on dosages that are actually delivered. In two consecutive acute lymphoblastic leukemia trials that differed in their asparaginase formulation, native E. coli L-asparaginase in St
Externí odkaz:
https://doaj.org/article/f2f424e701944bfb90237067ca32533f
Autor:
Katelyn N. Purvis, Hope D. Swanson, Kumar Kulldeep Niloy, Yiwang Zhou, John C. Panetta, Kristine R. Crews, Jamie E. Flerlage
Publikováno v:
Cancer Chemotherapy and Pharmacology.
Autor:
Satoshi Yoshimura, John C. Panetta, Jianzhong Hu, Lie Li, Yoshihiro Gocho, Guoqing Du, Akihiro Umezawa, Seth E. Karol, Ching-Hon Pui, Charles G. Mullighan, Marina Konopleva, Wendy Stock, David T. Teachey, Nitin Jain, Jun J. Yang
Publikováno v:
Leukemia.
Autor:
Joseph T. Opferman, Charles G. Mullighan, John D. Schuetz, Shondra M. Pruett-Miller, Meghan E. Turnis, Jon P. Connelly, John C. Panetta, Kathryn Roberts, John Lynch, Amit Budhraja, Kaitlyn H. Smith
sgRNA sequences for knockout cell lines and Synergy analysis of combinatorial drug treatments, determined by response surface modeling.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ceed2ed33e574ef374e58964a1e61e1
https://doi.org/10.1158/1541-7786.22526027.v1
https://doi.org/10.1158/1541-7786.22526027.v1
Autor:
Joseph T. Opferman, Charles G. Mullighan, John D. Schuetz, Shondra M. Pruett-Miller, Meghan E. Turnis, Jon P. Connelly, John C. Panetta, Kathryn Roberts, John Lynch, Amit Budhraja, Kaitlyn H. Smith
Densitometry for immunoblots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b182c450af8015aa1646003d7e491cd7
https://doi.org/10.1158/1541-7786.22526030
https://doi.org/10.1158/1541-7786.22526030
Autor:
Joseph T. Opferman, Charles G. Mullighan, John D. Schuetz, Shondra M. Pruett-Miller, Meghan E. Turnis, Jon P. Connelly, John C. Panetta, Kathryn Roberts, John Lynch, Amit Budhraja, Kaitlyn H. Smith
Antiapoptotic MCL1 is one of the most frequently amplified genes in human cancers and elevated expression confers resistance to many therapeutics including the BH3-mimetic agents ABT-199 and ABT-263. The antimalarial, dihydroartemisinin (DHA) transla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46ccea3a5dac684fc5225e64f21e6f0d
https://doi.org/10.1158/1541-7786.c.6544988.v1
https://doi.org/10.1158/1541-7786.c.6544988.v1
Autor:
Clinton F. Stewart, Amar Gajjar, Sue C. Kaste, Justin N. Baker, Thomas E. Merchant, Thomas K. Chin, John C. Panetta, Arzu Onar-Thomas, Andrew M. Davidoff, Jie Huang, Atmaram S. Pai Panandiker, Cynthia Wetmore, Sharyn D. Baker, Alberto Broniscer
Purpose: Testing of promising drug combinations is crucial in the treatment of diffuse intrinsic pontine glioma (DIPG). As the VEGF and platelet-derived growth factor (PDGF) pathways are critical in gliomas, we evaluated the safety, maximum tolerated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5543b396f7553cae8ae886f0945f95e9
https://doi.org/10.1158/1078-0432.c.6522533.v1
https://doi.org/10.1158/1078-0432.c.6522533.v1